Your browser doesn't support javascript.
loading
Worsening of Psychotic Symptoms in Patients with Chronic Schizophrenia after Switching to or Combining Aripiprazole and Aripiprazole Monthly (Abilify Maintena) / 신경정신의학
Journal of Korean Neuropsychiatric Association ; : 166-169, 2020.
Article | WPRIM | ID: wpr-836027
ABSTRACT
Objectives@#Aripiprazole is an antipsychotic that functions as a partial agonist in hypodopaminergic states and a dopamine antagonist in hyperdopaminergic states. @*Methods@#This paper reports a series of five clinical cases of worsening psychotic symptoms in schizophrenic patients related to the initiation of aripiprazole, oral and injection, as combination therapy. @*Results@#In all five cases, the switching of aripiprazole improved the psychotic symptoms. @*Conclusion@#Even with the suggestive relationship between aripiprazole therapy and the worsening of psychotic symptoms, further research is needed.
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Etude diagnostique Texte intégral: Journal of Korean Neuropsychiatric Association Année: 2020 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Etude diagnostique Texte intégral: Journal of Korean Neuropsychiatric Association Année: 2020 Type: Article